Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210425534> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4210425534 abstract "Cyclophosphamide is used for the treatment of lymphoma, leukaemia, some solid tumours, and autoimmune disorders. When carrying out myeloablative cytostatic therapy, the doses of cyclophosphamide are prescribed, which cause irreversible pancytopenia. Early toxic effects of such doses are manifested by asthenic and emetic syndromes, limiting the treatment tolerance. Administration of cyclophosphamide in a dose of ≥ 600 mg/kg is accompanied by hyperammonaemia and symptoms, specific to the acute ammonium salt intoxication. Endotoxemia, resulting from the increase in the intestinal barrier permeability due to the impaired gastrointestinal motility, is considered the possible mechanism underlying these phenomena. The study was aimed to test this hypothesis. Radiographic assessment of the rat gastrointestinal peristalsis was performed within 25 h after administration of cyclophosphamide in a dose of 1000 mg/kg, which was equivalent to myeloablative dose for humans. Intraperitoneal, subcutaneous or intragastric administration of cyclophosphamide slowed down the gastrointestinal transit of bariumsulfate. In the case of subcutaneous cyclophosphamide injection, a moderate effect was observed. In the case of cyclophosphamide administered by gavage, the effect was manifested by a complete halt of transit. Thus, modelling myeloablative cytostatic therapy with cyclophosphamide in rats is associated with gastrointestinal stasis. The changes reported may promote the entry of the gut microbial products into the bloodstream and ensuing endotoxemia." @default.
- W4210425534 created "2022-02-08" @default.
- W4210425534 creator A5003880583 @default.
- W4210425534 creator A5033640290 @default.
- W4210425534 creator A5087365552 @default.
- W4210425534 date "2022-01-01" @default.
- W4210425534 modified "2023-10-01" @default.
- W4210425534 title "Modelling myeloablative cytostatic therapy with cyclophosphamide is accompanied by gastrointestinal stasis in rats" @default.
- W4210425534 cites W1548393216 @default.
- W4210425534 cites W1901299664 @default.
- W4210425534 cites W1989442238 @default.
- W4210425534 cites W1989477219 @default.
- W4210425534 cites W1992383932 @default.
- W4210425534 cites W1998794592 @default.
- W4210425534 cites W2004428852 @default.
- W4210425534 cites W2049819798 @default.
- W4210425534 cites W2079400961 @default.
- W4210425534 cites W2082965698 @default.
- W4210425534 cites W2105253784 @default.
- W4210425534 cites W2313209214 @default.
- W4210425534 cites W2468919472 @default.
- W4210425534 cites W2570042144 @default.
- W4210425534 cites W2586368049 @default.
- W4210425534 cites W2769035034 @default.
- W4210425534 cites W2895838653 @default.
- W4210425534 cites W2899113210 @default.
- W4210425534 cites W2946919155 @default.
- W4210425534 doi "https://doi.org/10.47183/mes.2022.001" @default.
- W4210425534 hasPublicationYear "2022" @default.
- W4210425534 type Work @default.
- W4210425534 citedByCount "1" @default.
- W4210425534 countsByYear W42104255342022 @default.
- W4210425534 crossrefType "journal-article" @default.
- W4210425534 hasAuthorship W4210425534A5003880583 @default.
- W4210425534 hasAuthorship W4210425534A5033640290 @default.
- W4210425534 hasAuthorship W4210425534A5087365552 @default.
- W4210425534 hasBestOaLocation W42104255341 @default.
- W4210425534 hasConcept C126322002 @default.
- W4210425534 hasConcept C2776694085 @default.
- W4210425534 hasConcept C2776755627 @default.
- W4210425534 hasConcept C2778670039 @default.
- W4210425534 hasConcept C2780512811 @default.
- W4210425534 hasConcept C71924100 @default.
- W4210425534 hasConcept C90924648 @default.
- W4210425534 hasConcept C98274493 @default.
- W4210425534 hasConceptScore W4210425534C126322002 @default.
- W4210425534 hasConceptScore W4210425534C2776694085 @default.
- W4210425534 hasConceptScore W4210425534C2776755627 @default.
- W4210425534 hasConceptScore W4210425534C2778670039 @default.
- W4210425534 hasConceptScore W4210425534C2780512811 @default.
- W4210425534 hasConceptScore W4210425534C71924100 @default.
- W4210425534 hasConceptScore W4210425534C90924648 @default.
- W4210425534 hasConceptScore W4210425534C98274493 @default.
- W4210425534 hasIssue "2022(1)" @default.
- W4210425534 hasLocation W42104255341 @default.
- W4210425534 hasOpenAccess W4210425534 @default.
- W4210425534 hasPrimaryLocation W42104255341 @default.
- W4210425534 hasRelatedWork W1998694088 @default.
- W4210425534 hasRelatedWork W2014152824 @default.
- W4210425534 hasRelatedWork W2019694656 @default.
- W4210425534 hasRelatedWork W2019852837 @default.
- W4210425534 hasRelatedWork W2060816095 @default.
- W4210425534 hasRelatedWork W2073371839 @default.
- W4210425534 hasRelatedWork W2405895618 @default.
- W4210425534 hasRelatedWork W2416566838 @default.
- W4210425534 hasRelatedWork W2473286505 @default.
- W4210425534 hasRelatedWork W2620183848 @default.
- W4210425534 isParatext "false" @default.
- W4210425534 isRetracted "false" @default.
- W4210425534 workType "article" @default.